investors. Such new regime would promote a market environment conducive to competition in line with the Ease-of-Doing-Business Policy of the public sector. The new regime would also keep the existing
to market their ARFP funds, and make other necessary preparations for the coming of foreign competition by developing new products that truly respond to Thai investors? demands
attracting or persuading investors to make their decision because of premiums or gifts. ?Amid the current high competition environment, advertising and sales promotions produced by business operators often
preparation for more intense competition. At the end, Thai capital market will be more developed both in horizontal and vertical dimensions,? said Mr. Vorapol.
2017. The details are as follow : Unit : Million baht 2018 2017 Dividend received from - The company in SET 140.17 178.62 - The Medic Pharma Co.,Ltd. 0.86 0.86 - Buranavetch Co.,Ltd. 5.70 5.70 - Thai
-0135 www.interpharma.co.th Inter Pharma Public Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th IP_AC
Ranking IRC INOUE RUBBER (THAILAND) PUBLIC COMPANY LIMITED Filing FinancialStatement 56-1 56-2 Ranking IVF INSPIRE IVF Public Company Limited Filing FinancialStatement 56-1 56-2 Ranking IP INTER PHARMA
Inter Pharma Public Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th IP_OCS/009/2562 วนัท่ี 4
์02-634-0135 www.interpharma.co.th Inter Pharma Public Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135